The US-based firm now has nearly 20 per cent of its staff based in Asia, and has invested $US13.7 billion across the region since inception. The firm kicked off fundraising on its eighth Asia-focused buyout fund at the start of this year, targeting $US6 billion.

In deals, TPG is due to finalise its acquisition of Singapore-based iNova Pharmaceuticals, which has a big Australian presence, in coming weeks. TPG won an auction to acquire the business in July.